Litcius/Paper detail

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Unknown authors

2023New England Journal of Medicine11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineGastroesophageal JunctionNivolumabEsophageal cancerAdjuvantEsophagogastric junctionCancerInternal medicineGastroenterologyOncologyAdenocarcinomaImmunotherapyEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersGastric Cancer Management and Outcomes